Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia

FASEB Journal

Volumn 20, Issue 14, 2006, Pages

  Von Degenfeld, Georges ^a,c   Banfi, Andrea ^a,d   Springer, Matthew L ^a,e   Wagner, Roger A ^b   Jacobi, Johannes ^b   Ozawa, Clare R ^a   Merchant, Milton J ^a   Cooke, John P ^b   Blau, Helen M ^a,b  

^a Baxter Laboratory in Genetic Pharmacology   (Germany)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Cardiovascular Research   (Germany)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Cell transplantation; Gene therapy

Indexed keywords

VASCULOTROPIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ARTICLE; BLOOD FLOW; CONTROLLED STUDY; HEMANGIOMA; IN VIVO STUDY; MALE; MOUSE; MUSCLE ISCHEMIA; MYOBLAST; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANGIOGENESIS; ANIMAL; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HINDLIMB; ISCHEMIA; METABOLISM; PHYSIOLOGY; SKELETAL MUSCLE; VASCULARIZATION;

ANIMALS; GENE EXPRESSION REGULATION; HINDLIMB; ISCHEMIA; MALE; MICE; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33845668287     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-6568fje     Document Type: Article

References (37)

1. Simons, M. (2005) Angiogenesis: where do we stand now? Circulation 111, 1556-1566
2. Deindl, E., Buschmann, I., Hoefer, I. E., Podzuweit, T., Boengler, K., Vogel, S., van Royen, N., Fernandez, B., and Schaper, W. (2001) Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ. Res. 89, 779-786
3. Masaki, I., Yonemitsu, Y., Yamashita, A., Sata, S., Tanii, M., Komori, K., Nakagawa, K., Hou, X., Nagai, Y., and Hasegawa, M., et al (2002) Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ. Res. 90, 966-973
4. Hershey, J. C., Baskin, E. P., Corcoran, H. A., Bett, A., Dougherty, N. M., Gilberto, D. B., Mao, X., Thomas, K. A., and Cook, J. J. (2003) Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits. Heart Vessels 18, 142-149
5. Zhou, Y. F., Stabile, E., Walker, J., Shou, M., Baffour, R., Yu, Z., Rott, D., Yancopoulos, G. D., Rudge, J. S., and Epstein, S. E. (2004) Effects of gene delivery on collateral development in chronic hypoperfusion: diverse effects of angiopoietin-1 versus vascular endothelial growth factor. J Am Coll Cardiol. 44, 897-903
6. Gounis, M. J., Spiga, M. G., Graham, R. M., Wilson, A., Haliko, S., Lieber, B. B., Wakhloo, A. K., and Webster, K. A. (2005) Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle. Gene Ther. 12, 762-771
7. Schwarz, E. R., Speakman, M. T., Patterson, M., Hale, S. S., Isner, J. M., Kedes, L. H., and Kloner, R. A. (2000) Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat-angiogenesis and angioma formation. J Am Coll Cardiol. 35, 1323-1330
8. Banfi, A., von Degenfeld, G., and Blau, H. M. (2005) Critical role of microenvironmental factors in angiogenesis. Curr Atheroscler Rep. 7, 227-234
9. Ozawa, C. R., Banfi, A., Glazer, N. L., Thurston, G., Springer, M. L., Kraft, P. E., McDonald, D. M., and Blau, H. M. (2004) Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J. Clin. Invest. 113, 516-527
10. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439
11. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., and Moore, M. W. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442
12. Miquerol, L., Langille, B. L., and Nagy, A. (2000) Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 127, 3941-3946
13. Dor, Y., Djonov, V., Abramovitch, R., Itin, A., Fishman, G. I., Carmeliet, P., Goelman, G., and Keshet, E. (2002) Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J. 21, 1939-1947
14. Sundberg, C., Nagy, J. A., Brown, L. F., Feng, D., Eckelhoefer, I. A., Manseau, E. J., Dvorak, A. M., and Dvorak, H. F. (2001) Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am. J. Pathol. 158, 1145-1160
15. Springer, M. L., Chen, A. S., Kraft, P. E., Bednarski, M., and Blau, H. M. (1998) VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cell. 2, 549-558
16. Luttun, A., Tjwa, M., Moons, L., Wu, Y., Angelillo-Scherrer, A., Liao, F., Nagy, J. A., Hooper, A., Priller, J., De Klerck, B., et al. (2002) Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat. Med. 8, 831-840
17. Vajanto, I., Rissanen, T. T., Rutanen, J., Hiltunen, M. O., Tuomisto, T. T., Arve, K., Narvanen, O., Manninen, H., Rasanen, H., Hippelainen, M., et al. (2002) Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ. J. Gene Med. 4, 371-380
18. Rissanen, T. T., Markkanen, J. E., Arve, K., Rutanen, J., Kettunen, M. I., Vajanto, I., Jauhiainen, S., Cashion, L., Gruchala, M., Narvanen, O., et al. (2003) Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model. FASEB J. 17, 100-102
19. Thurston, G., Rudge, J. S., Ioffe, E., Zhou, H., Ross, L., Croll, S. D., Glazer, N., Holash, J., McDonald, D. M., and Yancopoulos, G. D. (2000) Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6, 460-463
20. Banfi, A., Springer, M. L., and Blau, H. M. (2002) Myoblast-mediated gene transfer for therapeutic angiogenesis. Methods Enzymol. 346, 145-157
21. Jacobi, J., Sydow, S., von Degenfeld, G., Zhang, Y., Dayoub, H., Wang, B., Patterson, A. J., Kimoto, M., Blau, H. M., and Cooke, J. P. (2005) Overexpression of dimethylarginine dimethylaminohydrolase (DDAH) reduces tissue ADMA levels and enhances angiogenesis. Circulation 111, 1431-1438
22. Scholz, D., Ziegelhoeffer, T., Helisch, A., Wagner, S., Friedrich, C., Podzuweit, T., and Schaper, W. (2002) Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J. Mol. Cell Cardiol. 34, 775-787
23. Chien, G. L., Anselone, C. G., Davis, R. F., and Van Winkle, D. M. (1995) Fluorescent vs. radioactive microsphere measurement of regional myocardial blood flow. Cardiovasc. Res. 30, 405-412
24. Thein, E., Raab, S., Harris, A. G., Kleen, M., Habler, O., Meisner, F., and Messmer, K. (2002) Comparison of regional blood flow values measured by radioactive and fluorescent microspheres. Eur. Surg. Res. 34, 215-223
25. Inai, T., Mancuso, M., Hashizume, H., Baffert, F., Haskell, A., Baluk, P., Hu-Lowe, D. D., Shalinsky, D. R., Thurston, G., Yancopoulos, G. D., and McDonald, D. M. (2004) Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am. J. Pathol. 165, 35-52
26. Rissanen, T. T., Markkanen, J. E., Gruchala, M., Heikura, T., Puranen, A., Kettunen, M. I., Kholova, I., Kauppinen, R. A., Achen, M. G., Stacker, et al. (2003) VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ. Res. 92, 1098-1106
27. Heeschen, C., Jang, J. J., Weis, M., Pathak, A., Kaji, S., Hu, R. S., Tsao, P. S., Johnson, F. L., and Cooke, J. P. (2001) Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat. Med. 7, 833-839
28. Paek, R., Chang, D. S., Brevetti, L. S., Rollins, M. D., Brady, S., Ursell, P. C., Hunt, T. K., Sarkar, R., and Messina, L. M. (2002) Correlation of a simple direct measurement of muscle pO(2) to a clinical ischemia index and histology in a rat model of chronic severe hindlimb ischemia. J. Vasc. Surg. 36, 172-179
29. Baffour, R., Garb, J. L., Kaufman, J., Berman, J., Rhee, S. W., Norris, M. A., and Friedmann, P. (2000) Angiogenic therapy for the chronically ischemic lower limb in a rabbit model. J. Surg. Res. 93, 219-229
30. Grinberg, O. Y., Hou, H., Grinberg, S. A., Moodie, K. L., Demidenko, E., Friedman, B. J., Post, M. J., and Swartz, H. M. (2004) pO2 and regional blood flow in a rabbit model of limb ischemia. Physiol. Meas. 25, 659-670
31. von Degenfeld, G., Raake, P., Kupatt, C., Lebherz, C., Hinkel, R., Gildehaus, F. J., Munzing, W., Kranz, A., Waltenberger, J., Simoes, M., et al. (2003) Selective pressure-regulated retro-infusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia. J. Am. Coll. Cardiol. 42, 1120-1128
32. Schaper, W., and Scholz, D. (2003) Factors regulating arteriogenesis. Arterioscler. Thromb. Vasc. Biol. 23, 1143-1151
33. Rissanen, T. T., Korpisalo, P., Markkanen, J. E., Liimatainen, T., Orden, M. R., Kholova, I., de Goede, A., Heikura, T., Grohn, O. H., and Yla-Herttuala, S. (2005) Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis. Circulation. 112, 3937-3946
34. Jain, R. K. (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307, 58-62
35. Ruhrberg, C., Gerhardt, H., Golding, M., Watson, R., Ioannidou, S., Fujisawa, H., Betsholtz, C., and Shima, D. T. (2002) Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev. 16, 2684-2698
36. Nehls, V., Denzer, K., and Drenckhahn, D. (1992) Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res. 270, 469-474
37. Morikawa, S., Baluk, P., Kaidoh, T., Haskell, A., Jain, R. K., and McDonald, D. M. (2002) Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am. J. Pathol. 160, 985-1000